Emmaus Life Sciences, Inc. is a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell disease. Emmaus Life Sciences, Inc. is a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell disease.
期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.0001 | -0.333333333333 | 0.03 | 0.03 | 0.027 | 45072 | 0.02710215 | CS |
4 | -0.0001 | -0.333333333333 | 0.03 | 0.0499 | 0.027 | 35665 | 0.02754393 | CS |
12 | 0.0279 | 1395 | 0.002 | 0.0499 | 0.002 | 35425 | 0.02870099 | CS |
26 | -0.0622 | -67.5352877307 | 0.0921 | 0.10115 | 0.0001 | 52214 | 0.02070462 | CS |
52 | -0.0701 | -70.1 | 0.1 | 0.135 | 0.0001 | 39403 | 0.05588412 | CS |
156 | -1.4401 | -97.9659863946 | 1.47 | 4 | 0.0001 | 28199 | 0.33646531 | CS |
260 | -2.2201 | -98.6711111111 | 2.25 | 4 | 0.0001 | 23947 | 0.74840608 | CS |
銘柄コード | 株価 | 出来高 |
---|---|---|
AITXArtificial Intelligence Technology Solutions Inc (PK) | US$ 0.00275 (0.00%) | 51.06M |
GTEHGenTech Holdings Inc (CE) | US$ 0.000001 (0.00%) | 48.25M |
HMBLHUMBL Inc (PK) | US$ 0.0002 (-33.33%) | 42.65M |
CBGLCannabis Global Inc (PK) | US$ 0.00015 (50.00%) | 41.81M |
GTVHGolden Triangle Ventures Inc (PK) | US$ 0.0008 (33.33%) | 41.61M |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約